Peter Cicala
Director/Miembro de la Junta en ETERNA THERAPEUTICS INC. .
Perfil
Peter Cicala is the founder of Boundless Bio, Inc. (founded in 2019).
He is currently working as an Independent Director at Eterna Therapeutics, Inc. since 2024.
Previously, he held the position of Chief Intellectual Property Counsel at Intercept Pharmaceuticals, Inc. from 2020 to 2021 and Chief Patent Counsel at Celgene Corp.
from 2014 to 2019.
Mr. Cicala completed his undergraduate degree at Fairleigh Dickinson University and his graduate degree at Seton Hall University School of Law.
Cargos activos de Peter Cicala
| Empresas | Cargo | Inicio |
|---|---|---|
| ETERNA THERAPEUTICS INC. | Director/Miembro de la Junta | 12/02/2024 |
Antiguos cargos conocidos de Peter Cicala.
| Empresas | Cargo | Fin |
|---|---|---|
| INTERCEPT PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/03/2021 |
| CELGENE | Corporate Officer/Principal | 01/11/2019 |
| BOUNDLESS BIO, INC. | Fundador | - |
Formación de Peter Cicala.
| Seton Hall University School of Law | Graduate Degree |
| Fairleigh Dickinson University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 3 |
|---|---|
| ETERNA THERAPEUTICS INC. | Health Technology |
| BOUNDLESS BIO, INC. | Health Technology |
| INTERCEPT PHARMACEUTICALS, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
- Bolsa de valores
- Insiders
- Peter Cicala
